How much does a box of Capmatinib cost?

Capmatinib (Capmatinib) is a kinase inhibitor that targets MET gene mutations. It is mainly used to treat patients with non-small cell lung cancer (NSCLC), especially cases carrying MET exon 14 skipping mutations. As an original drug developed by Novartis, capmatinib has shown good efficacy and tolerability in clinical trials, providing a new treatment direction for people with specific gene mutations. At present, the drug has been successfully launched in China and has been included in the medical insurance catalog, which has alleviated a certain financial burden on patients.

However, due to the short time that capmatinib has been on the market in China, hospitals and pharmacies in some areas may not have fully stocked it, so some patients still have difficulty purchasing the drug domestically. In this case, some patients choose to obtain capmatinib drugs through overseas channels. It should be noted that although the drug is covered by medical insurance, the actual reimbursement ratio and accessibility still depend on local policies and hospital implementation. Patients are advised to consult local medical institutions in advance.

In overseas markets, the price of capmatinib’s original drug is generally higher. A box of the drug is mostly sold for tens of thousands of yuan. The specific amount will vary depending on the specification, country and purchasing channel. Although original drugs have been fully verified in terms of efficacy and safety, they are expensive and long-term use puts a considerable strain on the patient's family economy. Therefore, some patients prefer to look for more cost-effective alternatives.

At present, Laos has launched a generic version of capmatinib. Its ingredients are basically the same as the original drug, and the price is affordable. A box of120 tablets of the generic drug costs only more than 2,000 yuan. This generic drug has attracted the attention and use of many overseas patients, and is especially suitable for patients who cannot afford the high cost of original drugs or who cannot purchase drugs through formal channels in the short term. However, it is important to remind patients that before choosing generic drugs, it is best to conduct an evaluation under the guidance of a professional doctor to ensure the safety and standardization of medication.

Reference materials:https://www.novartis.com/our-products/pipeline/capmatinib